FGFR3 and Miyoshi myopathy: Whether AMPK may be activated upon FGFR3 engagement on MM cells remains to be established, but it must be noted that AMPK activation inhibited the growth of MM cell lines by negatively regulating AKT [220], making it unlikely that AMPK signaling is involved in the oncogenic effects of FGFR3 in MM cells.